Matches in Nanopublications for { ?s ?p "DDI between Roflumilast and Tofacitinib - Roflumilast, when used in combination with tofacitinib, may increase the immunosuppressive effect of tofaciitinib and other immunosuppressive agents. It is recommended to modify therapy. [drugbank_resource:DB01656_DB08895]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB01656_DB08895 label "DDI between Roflumilast and Tofacitinib - Roflumilast, when used in combination with tofacitinib, may increase the immunosuppressive effect of tofaciitinib and other immunosuppressive agents. It is recommended to modify therapy. [drugbank_resource:DB01656_DB08895]" assertion.